I sat down with Caroline Colavita from BioCare Nutrition and Mario Testa from their parent company, Robard
They are starting to flex their product portfolio to match the D2C segment and start to fight hims & hers not just with lawsuits and FDA action but with real competition, too
By rejuvenating the tissue layer, the procedure appears to reset individuals' metabolism to their new post-GLP-1 weight, scientists say
Overall, tirzepatides efficacy and unique profile have generated interest in the therapeutic potential of GIP in type 2 diabetes, obesity, and related conditions
Picking between them, or stacking them, should come down to how each one actually works, not just habit or whatever you've seen other people running
If you do not exercise, it is recommended to continue consumption for a long time